32,200 Shares in Alignment Healthcare, Inc. $ALHC Purchased by Strs Ohio

Strs Ohio acquired a new stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 32,200 shares of the company's stock, valued at approximately $600,000.

Several other institutional investors have also added to or reduced their stakes in ALHC. MCF Advisors LLC raised its holdings in shares of Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock worth $40,000 after purchasing an additional 1,011 shares during the last quarter. Skandinaviska Enskilda Banken AB publ purchased a new stake in shares of Alignment Healthcare during the first quarter worth approximately $42,000. Amalgamated Bank grew its holdings in shares of Alignment Healthcare by 21.6% during the first quarter. Amalgamated Bank now owns 3,466 shares of the company's stock worth $65,000 after buying an additional 616 shares in the last quarter. Voloridge Investment Management LLC purchased a new stake in Alignment Healthcare during the 4th quarter valued at about $189,000. Finally, Regal Partners Ltd acquired a new stake in shares of Alignment Healthcare in the first quarter valued at approximately $194,000. Institutional investors and hedge funds own 86.19% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on ALHC shares. Stephens raised shares of Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. KeyCorp raised Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 target price for the company in a research report on Monday, August 25th. Barclays upgraded Alignment Healthcare from an "underweight" rating to an "equal weight" rating and increased their price objective for the company from $9.00 to $13.00 in a research note on Thursday, July 31st. Wall Street Zen cut shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, August 10th. Finally, Zacks Research raised shares of Alignment Healthcare to a "hold" rating in a research report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $18.83.

Insider Activity at Alignment Healthcare

In other Alignment Healthcare news, insider Christopher J. Joyce sold 30,939 shares of the business's stock in a transaction on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total value of $507,708.99. Following the sale, the insider owned 343,592 shares of the company's stock, valued at $5,638,344.72. The trade was a 8.26% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, President Dawn Christine Maroney sold 215,662 shares of the company's stock in a transaction dated Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total transaction of $3,539,013.42. Following the sale, the president directly owned 1,797,237 shares in the company, valued at $29,492,659.17. This represents a 10.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 7,388,173 shares of company stock worth $118,068,256 over the last quarter. 7.00% of the stock is currently owned by corporate insiders.

Alignment Healthcare Trading Up 0.4%

Alignment Healthcare stock opened at $16.54 on Friday. Alignment Healthcare, Inc. has a 1 year low of $9.15 and a 1 year high of $21.06. The firm's 50-day moving average is $14.70 and its 200-day moving average is $15.57. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66. The company has a market cap of $3.28 billion, a P/E ratio of -59.07 and a beta of 1.17.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. The company had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The business's revenue for the quarter was up 49.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.13) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, equities analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Want to see what other hedge funds are holding ALHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.